Ferdous M. Barlaskar

Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study

Eric Van Cutsem, Maria Di Bartolomeo, Elizabeth Smyth et al. · The Lancet Oncology · 2023 · 203 citations · Full text

Disease Progression, Gastrointestinal Oncology, Medicine +8

Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma

Ferdous M. Barlaskar, Aaron C. Spalding, Joanne H. Heaton et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 185 citations · Full text

Peroxisome Senescence in Human Fibroblasts

Julie E. Legakis, Jay I. Koepke, Chris Jedeszko et al. · Molecular Biology of the Cell · 2002 · 184 citations · Full text

Aging, Biochemistry, Peroxisomal Protein Import +13

Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin

Joanne H. Heaton, Michelle A. Wood, Alex C. Kim et al. · American Journal Of Pathology · 2012 · 165 citations · Full text

Phase 1/2 study of mRNA-4359 administered alone and in combination with immune checkpoint blockade in adult participants with advanced solid tumors.

John D. Powderly, Ryan J. Sullivan, Martin Gutierrez et al. · Journal of Clinical Oncology · 2023 · 18 citations

Pd-l1 Tps, Immunology, Immune Regulation +20